Shares of Select Medical Holdings Co. (NYSE:SEM) have been assigned a consensus recommendation of “Hold” from the six analysts that are covering the company, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 12-month price target among brokers that have covered the stock in the last year is $16.67.

Several equities analysts have recently weighed in on SEM shares. Zacks Investment Research upgraded Select Medical from a “strong sell” rating to a “hold” rating in a research report on Tuesday, March 12th. ValuEngine cut Select Medical from a “hold” rating to a “sell” rating in a report on Tuesday, March 5th. Barclays reaffirmed a “hold” rating and issued a $16.00 price target on shares of Select Medical in a report on Thursday, May 9th. TheStreet cut Select Medical from a “b-” rating to a “c+” rating in a report on Tuesday, March 26th. Finally, JMP Securities raised Select Medical from a “market perform” rating to an “outperform” rating and set a $18.00 price target for the company in a report on Friday, May 17th.

SEM stock traded down $0.13 during mid-day trading on Friday, reaching $15.05. 598 shares of the company’s stock were exchanged, compared to its average volume of 698,486. The company has a market capitalization of $2.04 billion, a P/E ratio of 14.72, a P/E/G ratio of 0.98 and a beta of 1.30. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 4.46. Select Medical has a 12-month low of $12.96 and a 12-month high of $21.65.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, May 2nd. The health services provider reported $0.27 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.27. The company had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.33 billion. Select Medical had a return on equity of 14.26% and a net margin of 2.80%. Select Medical’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.29 earnings per share. On average, research analysts predict that Select Medical will post 1.08 earnings per share for the current fiscal year.

In related news, Vice Chairman Rocco A. Ortenzio purchased 41,948 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The stock was purchased at an average price of $14.24 per share, with a total value of $597,339.52. Following the completion of the acquisition, the insider now owns 1,047,143 shares in the company, valued at $14,911,316.32. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Vice Chairman Rocco A. Ortenzio bought 306,189 shares of the business’s stock in a transaction on Monday, March 18th. The shares were acquired at an average cost of $14.18 per share, with a total value of $4,341,760.02. Following the purchase, the insider now owns 1,047,143 shares of the company’s stock, valued at $14,848,487.74. The disclosure for this purchase can be found here. 19.50% of the stock is currently owned by company insiders.

A number of hedge funds have recently bought and sold shares of the business. Jennison Associates LLC increased its stake in Select Medical by 0.9% during the first quarter. Jennison Associates LLC now owns 84,051 shares of the health services provider’s stock worth $1,184,000 after acquiring an additional 735 shares during the last quarter. Oregon Public Employees Retirement Fund increased its stake in Select Medical by 1.8% during the first quarter. Oregon Public Employees Retirement Fund now owns 41,931 shares of the health services provider’s stock worth $591,000 after acquiring an additional 757 shares during the last quarter. Piedmont Investment Advisors Inc. increased its stake in Select Medical by 3.2% during the fourth quarter. Piedmont Investment Advisors Inc. now owns 25,766 shares of the health services provider’s stock worth $396,000 after acquiring an additional 810 shares during the last quarter. LPL Financial LLC increased its stake in Select Medical by 8.2% during the fourth quarter. LPL Financial LLC now owns 10,980 shares of the health services provider’s stock worth $169,000 after acquiring an additional 836 shares during the last quarter. Finally, State of Alaska Department of Revenue increased its stake in Select Medical by 2.4% during the fourth quarter. State of Alaska Department of Revenue now owns 36,186 shares of the health services provider’s stock worth $555,000 after acquiring an additional 859 shares during the last quarter. 77.80% of the stock is owned by institutional investors.

About Select Medical

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Read More: How Do Mutual Funds Work?

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.